Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________________________________ FORM 10-K ___________________________________________________________ (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36751 _______________________ ...

Ocugen, Inc. (NASDAQ:OCGN) Q4 2019 Earnings Conference Call March 27, 2020 8:30 AM ET Company Participants Kelly Beck - Vice President, Investor Relations and Administration Shankar Musunuri - Chairman and Chief Executive Officer Sanjay Subramanian - Chief Financial Officer Dan Jorgensen - Chief Medical Officer Conference Call Participants Swayampakula Ramakanth - H.C. Wainwright Keay Nakae - Chardan Operator Good morning and welcome to the Ocugen Conference Call. At this time, all participants are in a l ...

Developing Transformative Therapies to Treat the Whole Eye NASDAQ: OCGN Corporate Deck Forward Looking Statement This presentation contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, contained in this presentation, including statements regarding our business strategy, future results of operations and financial position, prospective products, product approvals, research and development costs, timing and likelihood of ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36751 OCUGEN, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 04-3522315 (State or other jurisdiction of incorporation ...

Ocugen, Inc. (NASDAQ:OCGN) Q3 2019 Results Conference Call November 8, 2019 10:30 AM ET Company Participants Kelly Beck - Vice President, Investor Relations, Administration Shankar Musunuri - Chairman and Chief Executive Officer Sanjay Subramanian - Chief Financial Officer Conference Call Participants Swayampakula Ramakanth - H.C. Wainwright Operator Good morning, and welcome to Ocugen Conference Call. At this time all participants are in a listen-only mode. A question-and-answer session for research analys ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36751 Histogenics Corporation (Exact Name of Registrant as Specified in its Charter) Delaware 04-3522315 (State or other jurisdiction of incorpor ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-36751 Histogenics Corporation (Exact Name of Registrant as Specified in its Charter) Delaware 04-3522315 (State or other jurisdiction of incorpo ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36751 Histogenics Corporation (Exact name of registrant as specified in its charter) Delaware 04-3522315 (State or other jurisdiction o ...